B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection

• Published in: PLoS pathogens Vol. 18; no. 1; p. e1010179
• Main Authors: Ogega, Clinton O., Skinner, Nicole E., Flyak, Andrew I., Clark, Kaitlyn E., Board, Nathan L., Bjorkman, Pamela J., Crowe, James E., Cox, Andrea L., Ray, Stuart C., Bailey, Justin R.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.01.2022; Public Library of Science (PLoS)
• Subjects: Antibodies; Antigens; B cells; B-Lymphocytes - immunology; Biology and Life Sciences; Clearances; Dimensional analysis; Flow cytometry; Gene expression; Genetic aspects; Glycoprotein E2; Glycoproteins; Health aspects; Health care; Hepacivirus - immunology; Hepatitis C; Hepatitis C - immunology; Hepatitis C Antibodies - immunology; Hepatitis C virus; Humans; Immune response; Immunoglobulin G; Immunological memory; Infections; Lymphocytes; Lymphocytes B; Medicine and Health Sciences; Memory cells; PD-1 protein; Programmed Cell Death 1 Receptor - immunology; Proteins; Receptors, Fc - immunology; Research and Analysis Methods; Vaccine development; Vaccines; Viral Envelope Proteins - immunology; Viral infections; Viruses; United States
• ISSN: 1553-7374; 1553-7366; 1553-7374
• DOI: 10.1371/journal.ppat.1010179

Antibodies targeting the hepatitis C virus (HCV) envelope glycoprotein E2 are associated with delayed disease progression, and these antibodies can also facilitate spontaneous clearance of infection in some individuals. However, many infected people demonstrate low titer and delayed anti-E2 antibody responses. Since a goal of HCV vaccine development is induction of high titers of anti-E2 antibodies, it is important to define the mechanisms underlying these suboptimal antibody responses. By staining lymphocytes with a cocktail of soluble E2 (sE2) glycoproteins, we detected HCV E2-specific (sE2+) B cells directly ex vivo at multiple acute infection timepoints in 29 HCV-infected subjects with a wide range of anti-E2 IgG titers, including 17 persistently infected subjects and 12 subjects with spontaneous clearance of infection. We performed multi-dimensional flow cytometric analysis of sE2+ and E2-nonspecific (sE2-) class-switched B cells (csBC). In sE2+ csBC from both persistence and clearance subjects, frequencies of resting memory B cells (rMBC) were reduced, frequencies of activated MBC (actMBC) and tissue-like MBC (tlMBC) were increased, and expression of FCRL5, an IgG receptor, was significantly upregulated. Across all subjects, plasma anti-E2 IgG levels were positively correlated with frequencies of sE2+ rMBC and sE2+ actMBC, while anti-E2 IgG levels were negatively correlated with levels of FCRL5 expression on sE2+ rMBC and PD-1 expression on sE2+ actMBC. Upregulation of FCRL5 on sE2+ rMBC and upregulation of PD-1 on sE2+ actMBC may limit anti-E2 antibody production in vivo . Strategies that limit upregulation of these molecules could potentially generate higher titers of protective antibodies against HCV or other pathogens.